A wet wipe with a substrate having cellulosic fibers and a lotion is provided. The lotion may have between about 96.0% and about 99.5%, by weight of the lotion, of water. The lotion may have a preservative system having benzoic acid and/or a salt thereof, succinic acid and/or a salt thereof, and phytic acid and/or a salt thereof. The lotion may also have a pH buffering system and a pH of about 3.5 to about 5.

A pharmaceutical composition for treating skin infections is described herein. A method using a pharmaceutical composition for treating skin infections is described herein. A pharmaceutical composition for treating skin infections may comprise, in 100 parts of the composition, 1-99 parts of a pharmaceutically acceptable excipient; 99-1 parts of a keratolytic; 99-1 parts ethyl pyruvate; and 99-1 parts povidone iodine. A method for treating skin infections may comprise topical application of a composition to an infected skin cell for a treatment period.

The invention relates to a personal care product for alleviating skin dryness, includes facial skin dryness, breast skin dryness and vulval dryness and for restoring vaginal flora, acidic pH in the vagina, and vaginal health. Embodiments of the personal care product include a formulation including at least about 83 wt. % plant-based glycerides; from about 0.05 wt. % to about 0.15 wt. % sodium hyaluronate; and from about 0.01 wt. % to about 1.5 wt. % sea buckthorn powder. Another embodiment includes a personal care product including at least 55 wt. % plant-based glycerides and from about 20 wt. % to about 42 wt. % sucrose. The personal care product may also include shea olein. The person care product is substantially free of added water, alcohol, synthetic chemical, anti-microbial agent, and synthetic hormone.

A Camellia extract obtained by extracting by ultrasound a powder of Camellia japonica flowers, the powder being impregnated with a fatty substance or a mixture of fatty substances, with a hydroalcoholic solvent, and a cosmetic composition including such an extract having in particular a soothing effect for the skin. Also, a non-therapeutic use thereof for soothing the skin.

Compositions comprising select meroterpenes and a linoleic component and the use thereof in regulating the endocannabinoid system (ECS).

A bacterial ferment obtained by a method including the following steps: (a) culturing Lactobacillus species in at least one growth medium for at least 24 hours; (b) separating the mixture via centrifugation; (c) adding lactic acid to the supernatant obtained from step b) in an amount sufficient to lower the pH value of the supernatant; (d) stabilizing the resulting mixture with the addition of at least one preservative and/or at least one multifunctional; and optionally (e) filtering the mixture to remove any final precipitation.

The present invention provides a skin care preparation for babies, comprising: pharma grade water; at least one stabilizer; at least one nutrient; at least one emulsifier; wherein said preparation further comprises Zinc gluconate & magnesium asparate & copper gluconate (“SEPITONIC™-M3”) and Dunaliella salina extract.

The described invention provides a cosmetic composition formulated for topical application containing a water-based gel component comprising hyaluronic acid; a botanical ingredient component comprising decarboxylated cannabidiol (CBD) representing about 20% of an isolate, and a cosmetic composition stabilizing system comprising arginine, p-anisic acid, and levulinic acid, wherein the composition is a slightly viscous non-occluded water based liquid; pH of the finished product ranges from about 4.0 to about 5.0; and the composition is not psychoactive. The described invention also provides methods for promoting and maintaining vaginovulval and perianal tissue vitality and tissue health in a subject in need thereof by administering the composition topically to the subject.

The present invention relates generally to: a composition comprising or consisting of at least one avenantlrramide or an analogue thereof and 4-hydroxyacetophenone with an improved solubility; its cosmetic or medical use; the use of such composition N for the preparation of foods, food supplements, cosmetic, pharmaceutical or veterinary preparations; and foods, food supplements, cosmetic, pharmaceutical or veterinary perparations comprising such a composition. Finally, the present invention relates to 4-hydrox-yacetophenone for improving solutility of an avenantramide or an analogue thereof.

A feminine hygiene system contains one or more feminine hygiene products that establish, restore, or maintain an optimal vaginal microbiome, an optimal interior environment of the vagina, and healthy vaginal tissue, including ion concentrations and ratios in vaginal secretions. A method using the feminine hygiene system establishes, restores, or maintains an optimal vaginal microbiome, an optimal interior environment of the vagina, and healthy vaginal tissue, and alleviates vaginal discomfort or symptoms arising from medical or physiological causes.